Literature DB >> 12850356

Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative.

J Vandelaer1, M Birmingham, F Gasse, M Kurian, C Shaw, S Garnier.   

Abstract

Tetanus is a vaccine-preventable disease that yearly causes a total of 309,000 deaths. Of particular concern is maternal and neonatal tetanus (MNT), which can be prevented through immunization of the mother in pregnancy. In 2000, neonatal tetanus alone was responsible for an estimated 200,000 deaths. While the focus is on 57 priority countries, 90% of the neonatal tetanus deaths occur in 27 countries. UNICEF is spearheading the effort to eliminate MNT by the year 2005, with the support of numerous partners. MNT elimination is defined as less than one case of neonatal tetanus per 1000 live births at district level. The main strategies consist of promotion of clean delivery practices, immunization of women with a tetanus toxoid (TT) containing vaccine, and surveillance. Maternal tetanus immunization is, in most developing countries, implemented as part of the routine immunization program. However, large areas remain underserved, due to logistical, cultural, economical or other reasons. In order to achieve the target of MNT elimination by 2005, and to offer protection to women and children otherwise deprived from regular immunization services, countries are encouraged to adopt the "high risk approach". This approach implies that, in addition to routine immunization of pregnant women, all women of child bearing age living in high risk areas are targeted for immunization with three doses of a tetanus toxoid containing vaccine (TT or Td), implemented as "supplemental immunization activities" (SIAs). Through SIAs, about 17 million women have been reached with at least two doses of TT vaccine in the past 3 years, and it is estimated that another 200 million need to be targeted in the years to come. SIAs should substantially reduce the burden of disease. Countries will also have to improve their existing immunization and clean delivery programs to ensure that the elimination of maternal and neonatal tetanus is maintained.

Entities:  

Mesh:

Year:  2003        PMID: 12850356     DOI: 10.1016/s0264-410x(03)00347-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Neonatal tetanus elimination in India-still a long way to go.

Authors:  Vikrant Sood; Mukul Aggarwal; Kailash Chander Aggarwal
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

2.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children.

Authors:  Julie Rowe; Stephanie T Yerkovich; Peter Richmond; Devinda Suriyaarachchi; Elizabeth Fisher; Leonie Feddema; Richard Loh; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Risk factors for mortality in neonatal tetanus: a 15-year experience in Sagamu, Nigeria.

Authors:  Bolanle Musili Fetuga; Tinuade Adetutu Ogunlesi; Folashade Abiodun Adekanmbi
Journal:  World J Pediatr       Date:  2010-02-09       Impact factor: 2.764

Review 5.  Tetanus in Ethiopia: unveiling the blight of an entirely vaccine-preventable disease.

Authors:  Yohannes Woubishet Woldeamanuel
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

6.  Tetanus toxoid vaccine: elimination of neonatal tetanus in selected states of India.

Authors:  Ramesh Verma; Pardeep Khanna
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

7.  Basic health, women's health, and mental health among internally displaced persons in Nyala Province, South Darfur, Sudan.

Authors:  Glen Kim; Rabih Torbay; Lynn Lawry
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

8.  Rocuronium as Neuromuscular Blockade in Tetanus Patients With Methamphetamine Use Disorder: A Case Report.

Authors:  Robert Joseph Cruz Sarmiento; Clare Angeli G Enriquez; Francis Gerwin Jalipa; Bernadeth Lyn Piamonte; Jose Danilo Diestro; Carissa Paz Dioquino; Alberto Goffi; Roland Dominic G Jamora
Journal:  Neurohospitalist       Date:  2021-06-21

9.  Invasive group B streptococcal infection in infants, Malawi.

Authors:  Katherine J Gray; Sally L Bennett; Neil French; Amos J Phiri; Stephen M Graham
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Maternal Vaccination in Uganda: Exploring Pregnant Women, Community Leaders and Healthcare Workers' Perceptions.

Authors:  Phiona Nalubega; Emilie Karafillakis; Lydia Atuhaire; Pamela Akite; Flavia Zalwango; Tracey Chantler; Madeleine Cochet; Janet Seeley; Kirsty Le Doare
Journal:  Vaccines (Basel)       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.